Bio-Techne Corporation
TECH$11.40B
Large CapNASDAQBiological Products, (No Diagnostic Substances)Biotechnology🇺🇸North AmericaMINNEAPOLIS3.1K employees
Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.
Drugs in Pipeline
0
Phase 3 Programs
0
Upcoming Catalysts
1
Next Catalyst
May 12, 2026
4dMarket Overview
Stock performance and key metrics
TECH News
Catalyst Timeline
1 upcoming, 0 past
ConferenceNext
Conference Presentation
May 12, 2026AI-detected
Bio-Techne Corporation announced that President and CEO Kim Kelderman will present at the Bank of America Securities 2026 Global Healthcare Conference on May 12, 2026.
Drug Pipeline
No drugs found in this phase.
Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply